News

European leader in contamination control, has presented at the Annual Strategic Meeting the strategies which will guide its global expansion in the next five years

ROME, Nov. 4, 2024 /PRNewswire/ -- The plan provides for a targeted strengthening of current assets, with clear objectives of…

3 weeks ago

Axxess Names Channda Douglas Vice President of People

DALLAS, Nov. 4, 2024 /PRNewswire/ -- Axxess, the leading global technology platform for healthcare at home, announced today the appointment…

3 weeks ago

Beacon Communications Acquires Thompson Engineering, Gaining Additional Market Share in California’s Southern Region

National critical communications provider and technology consulting company acquires California-based Thompson Engineering as of October 22, 2024, to extend its…

3 weeks ago

Nestor Launches MyNestor: The First of Its Kind AI Booking Agent for Solo Professionals

LAFAYETTE, La., Nov. 4, 2024 /PRNewswire/ -- Nestor is excited to announce the launch of MyNestor, a groundbreaking AI booking…

3 weeks ago

Dario Expands Pharma Collaborations with Global Pharma Leader to Enhance User Engagement

The new platform services subscription contract with a top six U.S. pharma client marks a pivotal shift in Dario's pharma channel,…

3 weeks ago

Bio-K Plus Officially Launches New Line of Shelf-Stable Probiotic Capsules with Multi-Benefit Solutions on Amazon USA

NEW YORK, Nov. 4, 2024 /PRNewswire/ - Bio-K Plus, a Kerry Company and pioneer in the probiotic sector, is thrilled…

3 weeks ago

SeeMedX Files 510(k) with FDA for Innovative Cardiac Monitoring System to Transform Heart Failure Care

Transformative, non-invasive technology provides real-time insights into cardiac performance and fluid status, enabling clinicians to optimize heart failure treatment earlier…

3 weeks ago

CATALYX AND INEL FORGE STRATEGIC PARTNERSHIP TO ADVANCE PACKAGING AUTOMATION IN PHARMACEUTICAL MANUFACTURING

NEWTOWN, Pa., Nov. 4, 2024 /PRNewswire/ -- Catalyx, a global leader in machine vision and automation for highly regulated industries,…

3 weeks ago

Lonza’s Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC

Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studiesCollaboration underscores Lonza's commitment to…

3 weeks ago

OncoResponse to Present Phase 1 Results of Clinical Study of OR502, anti-LILRB2 Antibody, as a Late-Breaker Poster Presentation at SITC 2024

HOUSTON, Nov. 4, 2024 /PRNewswire/ -- OncoResponse, a clinical-stage biotech company advancing immunotherapies derived from the immune systems of Elite Cancer…

3 weeks ago